Literature DB >> 33614735

Severity of Intrarenal Arterial Lesions Can Predict the Clinical Prognosis of Hepatitis B Virus-Associated Glomerulonephritis: A Retrospective Study.

Yongze Zhuang1, Bo Liu1, Yinghao Yu2, Tianjun Guan3, Zhiyong Zheng2, Anqun Chen3.   

Abstract

BACKGROUND: Intrarenal arterial lesions (IALs) have been studied in immunoglobulin A nephropathy and lupus nephritis, but this has not been reported in hepatitis B virus-associated glomerulonephritis (HBV-GN). This study aims to investigate the prevalence and the role of IALs in HBV-GN.
METHODS: IALs were examined in kidney biopsy specimens from 205 patients with HBV-GN retrospectively. The severity of IALs and tubular interstitial lesions was scored semi-quantitatively. The severity of IALs was divided into 4 groups on the basis of ILA score, which were no IALs (Score 0), mild IALs (Score 1-2), moderate IALs (Score 3-4), and severe IALs (Score 5-10) groups. Survival analysis was performed using the Kaplan-Meier method between the severity of IALs and clinical events (doubling of serum creatinine [SCr], ESRD, and death due to the kidney disease).
RESULTS: Among 205 patients with HBV-GN, 143 (69.8%) had IALs in their kidney biopsy specimens. IALs were mild in 28 (19.6%) patients, moderate in 101 (70.6%) patients, and severe in 14 (9.8%) patients. The severity of IALs was associated with high blood pressure (BP), high SCr, and severe tubulointerstitial injuries. The average follow-up time of these 205 HBV-GN patients was 94.2 ± 47.1 months, in which 46 cases had clinical event. The proportions of clinical events in no IAL, mild IAL, moderate IAL, and severe IAL groups were 9.7, 14.3, 25.7, and 71.4%, respectively. Event-free survival of patient in IAL group was significantly lower than that in the no IAL group (p = 0.000). Multivariate cox regression analysis indicated SCr (1.011, 1.007-1.016), hypertension (1.767, 1.004-3.108), and IAL (2.194, 1.062-4.530) were independent risk factors for clinical events after adjustment for age and gender. Event-free clinical survival in moderate and severe IAL groups was significantly lower than that in the no IAL group (p = 0.0111 and p = 0.0001, respectively). Besides, event-free renal survival in severe IAL group was significantly lower than that in moderate IAL group (p = 0.009). Multivariate cox regression analysis showed that the more severe the IALs, the higher the risk of the clinical event, with a hazard ratio of 2.284 for moderate IALs (1.085-4.907) and 3.315 for severe IALs (1.296-8.482).
CONCLUSIONS: Severity of IALs is associated with high BP, reduced renal function, and poor clinical prognosis in HBV-GN patients.
Copyright © 2020 by S. Karger AG, Basel.

Entities:  

Keywords:  Hepatitis B virus-associated glomerulonephritis; Intrarenal arterial lesion; Renal biopsy; Tubular interstitial injury

Year:  2020        PMID: 33614735      PMCID: PMC7879251          DOI: 10.1159/000509088

Source DB:  PubMed          Journal:  Kidney Dis (Basel)        ISSN: 2296-9357


  26 in total

Review 1.  Tubulointerstitium as predictor of progression of glomerular diseases.

Authors:  G D'Amico
Journal:  Nephron       Date:  1999       Impact factor: 2.847

Review 2.  Hepatitis B virus-associated glomerular nephritis in East Asia: progress and challenges.

Authors:  Gaosi Xu; Tianlun Huang
Journal:  Eur J Intern Med       Date:  2010-12-18       Impact factor: 4.487

3.  Comparison of pathological lesions on repeated renal biopsies in 73 patients with primary IgA glomerulonephritis: value of quantitative scoring and approach to final prognosis.

Authors:  E Alamartine; J C Sabatier; F C Berthoux
Journal:  Clin Nephrol       Date:  1990-08       Impact factor: 0.975

4.  Renal vascular complications of systemic lupus erythematosus.

Authors:  G B Appel; C L Pirani; V D'Agati
Journal:  J Am Soc Nephrol       Date:  1994-02       Impact factor: 10.121

5.  Clinical and pathological analysis of hepatitis B virus-related membranous nephropathy and idiopathic membranous nephropathy.

Authors:  Ping Li; Ri-Bao Wei; Li Tang; Jie Wu; Xue-Guang Zhang; Xiang-Mei Chen
Journal:  Clin Nephrol       Date:  2012-12       Impact factor: 0.975

Review 6.  Renin-angiotensin system, hypertension, and chronic kidney disease: pharmacogenetic implications.

Authors:  Paulo Caleb Junior Lima Santos; Jose Eduardo Krieger; Alexandre Costa Pereira
Journal:  J Pharmacol Sci       Date:  2012       Impact factor: 3.337

7.  Study on hyperuricemia in HBV-associated glomerulonephritis.

Authors:  Yongze Zhuang; Yinghao Yu; Yingfang Huang; Xiaorong Zhong
Journal:  Am J Clin Pathol       Date:  2014-01       Impact factor: 2.493

8.  Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder: Synopsis of the Kidney Disease: Improving Global Outcomes 2017 Clinical Practice Guideline Update.

Authors:  Markus Ketteler; Geoffrey A Block; Pieter Evenepoel; Masafumi Fukagawa; Charles A Herzog; Linda McCann; Sharon M Moe; Rukshana Shroff; Marcello A Tonelli; Nigel D Toussaint; Marc G Vervloet; Mary B Leonard
Journal:  Ann Intern Med       Date:  2018-02-20       Impact factor: 25.391

Review 9.  Involvement of glomerular renin-angiotensin system (RAS) activation in the development and progression of glomerular injury.

Authors:  Shoji Kagami
Journal:  Clin Exp Nephrol       Date:  2011-12-02       Impact factor: 2.801

Review 10.  The Spectrum of Biopsy-Proven Glomerular Disease in China: A Systematic Review.

Authors:  Yue Yang; Zheng Zhang; Li Zhuo; Da-Peng Chen; Wen-Ge Li
Journal:  Chin Med J (Engl)       Date:  2018-03-20       Impact factor: 2.628

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.